Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
Armata Pharmaceuticals (NYSE American: ARMP), a biotechnology firm focused on bacteriophage therapeutics for antibiotic-resistant infections, will present at the Ladenburg Thalmann 2021 Healthcare Conference on July 13, 2021, at 4:00 PM ET. The event will feature one-on-one investor meetings and further details about Armata's innovative pipeline targeting pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus. Interested parties can access the presentation through a provided webcast link.
- None.
- None.
MARINA DEL REY, Calif., July 7, 2021 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will present and participate in one-on-one investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference taking place July 13-14, 2021.
Presentation details can be found below.
|
Date: |
Tuesday, July 13, 2021 |
|
Time: |
4:00 PM ET |
|
Webcast Link: |
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, known as MSD outside of the United States and Canada, Armata is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Media Contacts:
At Armata:
Steve Martin
Armata Pharmaceuticals, Inc.
ir@armatapharma.com
858-800-2492
Investor Relations:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
212-915-2569
View original content to download multimedia:https://www.prnewswire.com/news-releases/armata-pharmaceuticals-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference-301326239.html
SOURCE Armata Pharmaceuticals, Inc.
FAQ
When will Armata Pharmaceuticals present at the Ladenburg Thalmann 2021 Healthcare Conference?
What is the focus of Armata Pharmaceuticals?
Where can I find the webcast for Armata Pharmaceuticals' presentation?
What pathogens are targeted by Armata Pharmaceuticals' treatments?
What stock symbol represents Armata Pharmaceuticals?
